Articles récents
- IMD-Pharma uncovers the mechanism of action of its new asset in Rheumatoid Arthritis.
- IMD-Pharma signs a joint research agreement with the Inserm research unit U1291 (Infinity, PACID team, Toulouse).
- IMD-Pharma validates in vitro and in vivo a new lead for Rheumatoid Arthritis.
- IMD-Pharma hires Zakari Mouheb (biology), Laëtitia Lüdge (formulation) and Anthony Augé (chemistry) as apprentices in Master (12 months contract).
- IMD-Pharma signs a joint research agreement with the CNRS research unit UMR 5623 (IMRCP, SMODD team, Toulouse).
Commentaires récents
Aucun commentaire à afficher.